SEC Form SC 13G/A filed by VTEX (Amendment)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 03)*

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. This Amendment reports the same information contained in Amendment No.2 filed on February 14, 2024 but corrects an error marked in footnote 9 in Item 4.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G

¹ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and the Reporting Person's beneficial ownership of 3,034,335 Class B common shares convertible into one share of Class A Common per share.

SCHEDULE 13G

² Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and the Reporting Person's beneficial ownership of 32,153,276 Class B common shares convertible into one share of Class A Common per share.

SCHEDULE 13G

³ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and the Reporting Person's beneficial ownership of 14,767,304 Class B common shares convertible into one share of Class A Common per share.

SCHEDULE 13G

⁴ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and the Reporting Person's beneficial ownership of 2,000,000 Class B common share convertible into one share of Class A Common per share.

SCHEDULE 13G

⁵ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and the Reporting Person's beneficial ownership of 18,420,307 Class B common shares convertible into one share of Class A Common per share.

SCHEDULE 13G

⁶ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and the Reporting Person's beneficial ownership of no Class B common share convertible into one share of Class A Common per share.

SCHEDULE 13G

⁷ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, the Reporting Person's beneficial ownership of 35,187,611 Class B common shares convertible into one share of Class A Common per 1,625,000 Class A Common Shares currently exercisable and options to purchase 500,000 Class A Common Shares exercisable within 60 days of December 31, 2023.

SCHEDULE 13G

⁸ Based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in Exhibit 99.2 to the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, the Reporting Person's beneficial ownership of 35,187,611 Class B common shares convertible into one share of Class A Common per 1,125,000 Class A Common Shares currently exercisable and options to purchase 500,000 Class A Common Shares exercisable within 60 days of December 31, 2023.

VTEX (the "Issuer")

125 Kingsway, Wc2B 6NH

London, United Kingdom

Item 2.

Mira Limited

Abrolhos One Limited

Itacare Corporation

Signo Inv. Tech Co Ltd

Imbetiba Parent Ltd

Arbalete Fund Inc.

Marinao Gomide de Faria

Geraldo do Carmo Thomaz Junior

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."

The principal business office for each of Mira Limited, Abrolhos One Limited, Itacare Corporation, Signo Inv. Tech Co Ltd, Imbetibda Parent, and Arbalete Fund Inc. is:

Goodman's Bay Corporate Center, Second Floor

West Bay Street

P.O Box SP-61567

Nassau, Bahamas

The principal business office for each of Marinao Gomide de Faria and Geraldo do Carmo Thomaz Junior is:

c/o VTEX

10^th Floor, 12 E 49^th Street,

New York, NY 10017

See Item 4 of each cover page.

Class A common shares, $0.0001 par value per share ("Class A Common Shares").

G9470A102

Not applicable.

(a) Amount Beneficially Owned:

The information contained in rows 5,6,7,8,9,10 and 11 on each of the cover pages of this Schedule 13G is incorporated by reference in its entirety into this Item 4.

Beneficial ownership Class A Common Shares reported herein is based on 44,895 Class A Common Shares and 3,034,335 Class B common shares directly held by Mira Limited; 32,153,276 Class B common shares directly held by Abrolhos One Limited; 35,522 Class A Common Shares and 14,767,304 Class B common shares directly held by Itacare Corporation; 500,000 Class A Common Shares and 2,000,000 Class B common shares held by Signo Inv Tech Co Ltd; 18,420,307 Class B common shares held by Imbetiba Parent Ltd; 14,100 Class A Common Shares held by Arbalete Fund Inc. (for accounting purposes, 14,100 Class A shares are held exclusively by the Class M shares of Arbalete Fund Inc.); 10,000 Class A Common Shares, options to purchase 1,625,000 Class A Common Shares currently exercisable and options to purchase 500,000 Class A Common Shares exercisable within 60 days of December 31, 2023 held directly by Mariano Gomide de Faria; and 24,100 Class A Common Shares⁹, options to purchase 1,125,000 Class A Common Shares currently exercisable and options to purchase 500,000 Class A Common Shares within 60 days of December 31, 2023 held directly by Geraldo do Carmo Thomaz Junior.

Mariano Gomide de Faria is the sole member and director of Mira Limited. The controlling entity of Abrolhos One Limited is MGF Trust. MGF Trust shares control of Arbalete Fund Inc. with Thomaz Family Trust. MGF Trust controls Class M shares of Arbalete Fund Inc. Mr. Gomide de Faria serves as the investment advisor to MGF Trust, pursuant to which Mr. Gomide de Faria may make non-binding investment recommendations to MGF Trust. Onyx Partners Limited, as trustee of MGF Trust, may be deemed to have beneficial ownership over the common shares held by Abrolhos One Limited and Arbalete Fund Inc.

Geraldo do Carmo Thomaz Junior is the sole member and director of Itacare Corporation. The sole shareholder of each of Signo Inv. Tech Co Ltd and Imbetiba Parent Ltd is Thomaz Family Trust. Mr. do Carmo Thomaz Junior serves as the investment advisor to Thomaz Family Trust, pursuant to which Mr. do Carmo Thomaz Junior may make non-binding investment recommendations to Thomaz Family Trust. Onyx Patrners Limited, as trustee of Thomaz Family Trust shares control of Arbalete Fund Inc. with MGC Trust. Mr. do Carmo Thomaz Junior disclaims beneficial ownership of common shares held by Signo Inv. Tech Co Ltd and Imbetiba Parent Ltd.

⁹ Amendment 2 filed on February 14, 2024 incorrectly listed this number as 24,100,000. The correct number of Class A Shares held by Geraldo do Carmo Thomaz Junior is 24,100.

The filing of this Schedule 13G shall not be construed as an admission that the Reporting Persons are, for purposes of Sections 13(d) and 13(g) of the Securities Exchange Act of 1934, as amended, the beneficial owner of any of the shares reported herein that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the shares reported herein that are not directly owned by such Reporting Person.

Each Class A Common Share is entitled to one vote. Each Class B common share is entitled to ten votes and is convertible into one Class A Common Share, at the option of the holder and automatically upon transfer, subject to certain exceptions.

Calculations based upon 80,675,246 shares of Class A Common Shares outstanding as of April 21, 2023, as reported in the Issuer's 6-K filed with the Securities and Exchange Commission on April 26, 2023, and includes each Reporting Person's beneficial ownership of Class B common shares, and options to purchase Class A Common Shares, as applicable.

(b) Percent of class:

See Item 11 on the cover pages hereto.

(c) Number of Shares as to which the Reporting Person has:

(i) Sole power to vote or direct the vote:

See Item 5 on the cover pages hereto.

(ii) Shared power to vote or to direct the vote:

See Item 6 on the cover pages hereto.

(iii) Sole power to dispose or to direct the disposition of:

See Item 7 on the cover pages hereto.

(iv) Shared power to dispose or to direct the disposition of:

See Item 8 on the cover pages hereto.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

Not applicable.

Not applicable

The Reporting Persons have agreed to jointly file this Schedule 13G in accordance with Rule 13d-1(k) of the Act, the agreement with respect to which is attached hereto as Exhibit I. The filing of this statement should not be construed to be an admission that any member of the Reporting Persons are members of a "group" for purposes of Sections 13(d) and 13(g) of the Act.

Not applicable.

Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Exhibit I

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them Statements on Schedule 13D or Schedule 13G, as applicable (including amendments thereto), with regard to the securities of VTEX and further agree that this Joint Filing Agreement be included as an Exhibit to any such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this Agreement as of February 14, 2024.